Alyeska Investment Group, L.P. - ACER THERAPEUTICS INC ownership

ACER THERAPEUTICS INC's ticker is ACER and the CUSIP is 00444P108. A total of 17 filers reported holding ACER THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Alyeska Investment Group, L.P. ownership history of ACER THERAPEUTICS INC
ValueSharesWeighting
Q2 2018$1,642,000
-4.7%
76,009
-15.0%
0.02%
+7.1%
Q1 2018$1,723,000
+65.8%
89,398
+19.2%
0.01%
+75.0%
Q4 2017$1,039,00075,0000.01%
Other shareholders
ACER THERAPEUTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Worth Venture Partners, LLC 250,518$722,0000.59%
Nantahala Capital Management 990,655$2,853,0000.09%
GSA CAPITAL PARTNERS LLP 82,421$237,0000.04%
FEDERATED HERMES, INC. 117,673$339,0000.00%
BNP PARIBAS FINANCIAL MARKETS 179$516,0000.00%
Horan Securities, Inc. 24$00.00%
OSAIC HOLDINGS, INC. 200$1,0000.00%
BANK OF AMERICA CORP /DE/ 3$00.00%
WELLS FARGO & COMPANY/MN 29$00.00%
NORTHERN TRUST CORP 31,083$90,0000.00%
View complete list of ACER THERAPEUTICS INC shareholders